1. Home
  2. HPP vs DNA Comparison

HPP vs DNA Comparison

Compare HPP & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hudson Pacific Properties Inc.

HPP

Hudson Pacific Properties Inc.

HOLD

Current Price

$12.52

Market Cap

648.9M

Sector

Finance

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$9.54

Market Cap

562.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HPP
DNA
Founded
1997
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
648.9M
562.3M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
HPP
DNA
Price
$12.52
$9.54
Analyst Decision
Hold
Strong Sell
Analyst Count
12
1
Target Price
$19.89
$9.00
AVG Volume (30 Days)
1.2M
1.0M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$781,676,000.00
$180,606,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.08
$7.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.69
$5.00
52 Week High
$24.01
$17.58

Technical Indicators

Market Signals
Indicator
HPP
DNA
Relative Strength Index (RSI) 78.50 48.08
Support Level $12.91 $8.56
Resistance Level $14.21 $10.05
Average True Range (ATR) 0.55 0.55
MACD 0.67 0.28
Stochastic Oscillator 80.99 67.95

Price Performance

Historical Comparison
HPP
DNA

About HPP Hudson Pacific Properties Inc.

Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: